|
|
| MRD / Regn No. |
: 7612 |
Date |
: 22/06/2026 |
| Patient Name |
: Hazi Mansura Bibi |
Age & Gender |
: 68 Yrs. / Female |
| Contact No. |
: 9883780440 |
UHID |
: |
| Ht / Wt / BMI |
: 152 / 65 / 28.13 |
BP S / BP D |
: 154 / 80 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DIABETES (19/Oct/2011) | HYPOTHYROIDISM (19/Oct/2022) | HYPERTENSION (19/Oct/2022) | |
| Salient Investigations |
: |
CREATININE: 0.8 | EGFR EGLOMERULAR FILTRATION RATE: 76.43 mL/min/1.73m2 | HBA1C GLYCOSYLATED HEMOGLOBIN: 9.6 % | MICROALBUMIN CREATININE RATIO: 140 mcg/mg |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
TABLET THYROXINE 88 MCG
THYRONORM 88 MCG
Medicine For HYPOTHYROIDISM |
PO |
1-0-0 |
BEFORE BREAKFAST
|
TILL NEXT VISIT |
| MUST BE TAKEN ON AN EMPTY STOMACH. COFFEE TEA OR BREAKFAST MUST BE TAKEN ONLY AFTER 30 MINUTES. OTHER DRUGS CAN INTERFERE WITH THE ABSORPTION OF THYROXINE | |
|
2 |
TELMISARTAN 80 MG + CHLORTHALIDONE 12.5 MG
TELDAY H |
PO |
1-0-0 |
BEFORE BREAKFAST
|
TILL NEXT VISIT |
|
|
3 |
INJECTION DEGLUDEC / ASPART (INJ U100) 70/30
RYZODEG
Medicine For DIABETES |
SQ |
40-0-36 |
BEFORE BREAKFAST AND DINNER
|
TILL NEXT VISIT |
| MAY CAUSE HYPOGLYCEMIA | |
|
4 |
TABLET ROSUVASTATIN 10 MG
STATEZE R |
PO |
0-0-1 |
BEFORE DINNER
|
|
|
|
5 |
ANTIHYPERGLYCEMIC SITAGLIPTIN 100 MG + DAPAGLIFLOZIN 10 MG + METFORMIN 1000 MG
LUPISIT DM 1000 |
PO |
1-0-0 |
BEFORE BREAKFAST
|
TILL NEXT VISIT |
|
|
6 |
TABLET ACARBOSE 50 MG
GLUCOBAY 50 MG
Medicine For DIABETES |
PO |
0-1-0 |
BEFORE LUNCH
|
TILL NEXT VISIT |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 22/Dec/2026 |
| Tests Suggested For Next Visit |
: HBA1C-HPLC METHOD,CREATININE,RETINA CHECK UP,UACR:SPOT SAMPLE |
| |
|
| |
|
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal /
54020
This is a Computer generated Prescription |
Powered By:  |